WST West Pharmaceutical Services - Co and daikyo seiko enter amended crosslicense and distributorship agreements effective July 14, 2026 - S
WST West Pharmaceutical Services - Co and daikyo seiko enter amended crosslicense and distributorship agreements effective July 14, 2026 - SEC filing West Pharmaceutical Services Inc: Co maintains a 49% ownership interest in daikyo
WST West Pharmaceutical Services - Co and daikyo seiko enter amended crosslicense and distributorship agreements effective July 14, 2026 - SEC filing West Pharmaceutical Services Inc: Co maintains a 49% ownership interest in daikyo